Quarterly report pursuant to Section 13 or 15(d)

Revision to Prior Period Financial Statements (Tables)

v3.21.1
Revision to Prior Period Financial Statements (Tables)
3 Months Ended
Mar. 31, 2021
Prior Period Adjustment [Abstract]  
Summary of Revision to Prior Period Financial Statements
The Company concluded that the misstatement was not material to the
Post-IPO
Balance Sheet and the misstatement had no material impact to any prior interim period. The effect of the revisions to the
Post-IPO
Balance Sheet is as follows:
 
    
As of March 2, 2021
 
    
As Previously
Reported
    
Restatement
Adjustment
    
As Restated
 
Balance Sheet
                          
Total assets
   $ 277,526,800      $ —        $ 277,526,800  
    
 
 
    
 
 
    
 
 
 
Liabilities and shareholders’ equity
                          
Total current liabilities
   $ 710,251      $ —        $ 710,251  
Deferred underwriting commissions
     9,625,000        —          9,625,000  
Warrant liabilities
     —          9,153,333        9,153,333  
    
 
 
    
 
 
    
 
 
 
Total liabilities
     10,335,251        9,153,333        19,488,584  
Class A ordinary shares, $0.001 par value; shares subject to possible redemption
     262,191,540        (9,153,330      253,038,210  
Shareholders’ equity
                          
Preference shares - $0.0001 par value
     —          —          —    
Class A ordinary shares - $0.001 par value
     128        92        220  
Class B ordinary shares - $0.001 par value
     690        —          690  
Additional
paid-in-capital
     5,052,066        275,527        5,327,593  
Accumulated deficit
     (52,875      (275,622      (328,497
    
 
 
    
 
 
    
 
 
 
Total shareholders’ equity
     5,000,009        (3      5,000,006  
    
 
 
    
 
 
    
 
 
 
Total liabilities and shareholders’ equity
   $ 277,526,800      $ —        $ 277,526,800